Open Access
Research Paper
Peer Reviewed

Paper Title

Species Distribution And Antifungal Susceptibility Of Candida Species In Blood Culture Isolated From A Tertiary Care Hospital In Odisha: Our Experience

Article Identifiers

Registration ID: IJNRD_184690

Published ID: IJNRD2212066

: Click Here to Get

Keywords

candidaemia, Blood stream infections, Fungemia, nosocromial, emerging fungal pathogens.

Abstract

Blood stream infections caused by species of Candida may occur both in the community and in the hospital admitted patients and are the cause of significant morbidity ,mortality and health care cost.Difficulty in detection of fungus in clinical specimen is an important cause of less studies on fungal blood stream infections than bacterial.The present study was done with the aim of to determine the species distribution of Candida in blood stream infections and antifungal susceptibility patterns of different species of candida isolated from blood samples collected from patients admitted in different wards of the SUM hospital, Odisha and in patients attending OPD of the same hospital during the study period(2 years from January 2020 to December 2021). Species-level identification and antifungal susceptibility of these fungal isolates were performed using a fully automated VITEK 2 machine.Of the 2746 blood samples obtained from OPD, IPD and ICU during the last 2 years, a total of 166 (6.04%) blood samples were positive for yeast. 115 (69.27%) were from the intensive care unit (ICU), 43 (25.9%) from other wards and 8 (4.81%) were from OPD. Most common species isolated was Candida auris in patients with different clinical diagnosis, C.auris 66 (40.74%), C.parapsilosis29 (18%), C.tropicalis20 (12.34%), C. albicans 18 (11.11%), C. dobushaemulonii 13 (802%), C.glabrata 6 (3.70%), C.pelliculosa 3 (1.85%), C.famata2 (1.23%), C.lipolytica2 (1.23%), C.gullienmondii 2 (1.23%), C.kefyr 1 (0.6%). Male affected 61.44% and female affected 38.55%. Automated culture system (VITEK) must include C.auris. Additionally, hospitals should update their own protocols for antifungal drug use by evaluating yeast species growing in their own units. Consultation with an infectious disease specialist should be part of the protocol when treating candidaemia.

How To Cite (APA)

Dr. Nabanita Chakraborti, Dr. Pragyan Paramita Jena, & Prof.Dr.Kundan Kumar Sahu (December-2022). Species Distribution And Antifungal Susceptibility Of Candida Species In Blood Culture Isolated From A Tertiary Care Hospital In Odisha: Our Experience. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 7(12), a467-a475. https://ijnrd.org/papers/IJNRD2212066.pdf

Issue

Other Publication Details

Paper Reg. ID: IJNRD_184690

Published Paper Id: IJNRD2212066

Downloads: 000122255

Research Area: Medical Science

Author Type: Indian Author

Country: Bhubaneswar, Odisha, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2212066.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2212066

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Copyright & License

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
CC OpenContant

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 10 | Issue 12 | December 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.


For more details, refer to the official notice: UGC Public Notice


Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: December 2025

Current Issue: Volume 10 | Issue 12 | December 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Dec-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details